Clinical Trial Update: Prevascar in African Continental Group Scarring [Phase 1]

View source ↗

Summary

Phase 1 trial of Prevascar by Renovo for scarring, with the trial status shown as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scarring

Drugs mentioned

• Prevascar

Snippet

Sponsor: Renovo | Conditions: Scarring | Phase 1 | Status: UNKNOWN